BRPI0516219A - composto de carboestirila - Google Patents
composto de carboestirilaInfo
- Publication number
- BRPI0516219A BRPI0516219A BRPI0516219-0A BRPI0516219A BRPI0516219A BR PI0516219 A BRPI0516219 A BR PI0516219A BR PI0516219 A BRPI0516219 A BR PI0516219A BR PI0516219 A BRPI0516219 A BR PI0516219A
- Authority
- BR
- Brazil
- Prior art keywords
- hydrogen atom
- carbostyril
- diseases
- bond
- compound
- Prior art date
Links
- LISFMEBWQUVKPJ-UHFFFAOYSA-N carbostyril Natural products C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title abstract 5
- -1 carbostyril compound Chemical class 0.000 title abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000025157 Oral disease Diseases 0.000 abstract 1
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000001118 alkylidene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000030194 mouth disease Diseases 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 208000011479 upper respiratory tract disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
COMPOSTO DE CARBOESTIRILA. A presente invenção fornece um composto de carboestirila representado pela Fórmula Geral (1) ou um sal deste, em que A é uma ligação direta, um grupo de alquileno inferior, ou um grupo de alquilideno inferior; X é um átomo de oxigênio ou um átomo de enxofre; R~ 4~ e R~ 5~ cada qual representa um átomo de hidrogênio; a ligação entre as posições 3 e 4 do esqueleto de carboestirila é uma ligação simples ou uma ligação dupla; R¹ é um átomo de hidrogênio, etc; R² é um átomo de hidrogênio, etc; e R³ é um átomo de hidrogênio, etc. O composto de carboestirila ou sal deste da presente invenção induz a produção de TFF e desse modo é utilizável para o tratamento e/ou prevenção de distúrbios tais como doenças do trato alimentar, doenças orais, doenças do trato respiratório superior, doenças do trato respiratório, doenças de olho, cânceres e ferimentos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004282814 | 2004-09-28 | ||
| PCT/JP2005/018217 WO2006035954A1 (en) | 2004-09-28 | 2005-09-26 | Carbostyril compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0516219A true BRPI0516219A (pt) | 2008-08-26 |
Family
ID=36119093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0516219-0A BRPI0516219A (pt) | 2004-09-28 | 2005-09-26 | composto de carboestirila |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7777038B2 (pt) |
| EP (2) | EP2426128A1 (pt) |
| JP (1) | JP3906471B1 (pt) |
| KR (2) | KR100840465B1 (pt) |
| CN (1) | CN101068810B (pt) |
| AR (1) | AR055193A1 (pt) |
| AU (2) | AU2005288080B2 (pt) |
| BR (1) | BRPI0516219A (pt) |
| CA (1) | CA2580811C (pt) |
| ES (1) | ES2393197T3 (pt) |
| IL (2) | IL181630A0 (pt) |
| MX (1) | MX2007003735A (pt) |
| RU (2) | RU2430920C2 (pt) |
| TW (1) | TWI353353B (pt) |
| WO (1) | WO2006035954A1 (pt) |
| ZA (1) | ZA200702228B (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0516219A (pt) * | 2004-09-28 | 2008-08-26 | Otsuka Pharma Co Ltd | composto de carboestirila |
| EP1900732A4 (en) * | 2005-06-24 | 2009-11-18 | Toyama Chemical Co Ltd | NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF |
| JP5191155B2 (ja) * | 2006-03-27 | 2013-04-24 | 大塚製薬株式会社 | カルボスチリル化合物からなる医薬 |
| CA2651700A1 (en) * | 2006-05-22 | 2007-11-29 | Merck Frosst Canada Ltd. | Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| RU2009105891A (ru) * | 2006-07-20 | 2010-08-27 | Оцука Фармасьютикал Ко., Лтд. (Jp) | ИНГИБИТОР NF-кВ |
| WO2008079787A2 (en) * | 2006-12-20 | 2008-07-03 | Takeda San Diego, Inc. | Glucokinase activators |
| NZ597381A (en) | 2007-09-14 | 2013-03-28 | Metabolic Solutions Dev Co Llc | Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases |
| US8304441B2 (en) | 2007-09-14 | 2012-11-06 | Metabolic Solutions Development Company, Llc | Thiazolidinedione analogues for the treatment of metabolic diseases |
| DK2513070T3 (en) | 2009-12-15 | 2018-01-22 | Cirius Therapeutics Inc | PPAR-sparing thiazolidinedione salts for the treatment of metabolic disorders |
| JP2015525223A (ja) | 2012-06-14 | 2015-09-03 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 動物有害生物を駆除するための置換３−ピリジルチアゾール化合物および誘導体を使用する有害生物防除方法 |
| RU2523387C1 (ru) * | 2013-03-19 | 2014-07-20 | Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ 6-[(4-МЕТИЛ-I-1-ПИПЕРАЗИНИЛ)МЕТИЛ]-ИНДОЛО[1',7':1,2,3]ПИРРОЛО[3',4':6,7]АЗЕПИНО[4,5-b]ИНДОЛ-1,3(2Н,10 Н)-ДИОНА В КАЧЕСТВЕ ПРОТИВООПУХОЛЕВОГО СРЕДСТВА |
| KR102084185B1 (ko) | 2013-08-29 | 2020-03-04 | 주식회사 대웅제약 | 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법 |
| LT3092227T (lt) * | 2014-01-09 | 2018-08-10 | Orion Corporation | Bicikliniai heterocikliniai dariniai kaip bromodomeno inhibitoriai |
| US20160346303A1 (en) | 2014-10-29 | 2016-12-01 | Glycom A/S | Synthetic composition and method for treating irritable bowel syndrome |
| GB2532990A (en) | 2014-12-05 | 2016-06-08 | Schlumberger Holdings | Corrosion inhibition |
| GB2543498A (en) | 2015-10-19 | 2017-04-26 | Schlumberger Holdings | Corrosion inhibition |
| WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
| CN108948029A (zh) * | 2017-05-27 | 2018-12-07 | 华中科技大学 | 菲啶酮衍生物及其合成方法和抗肿瘤应用 |
| US10324266B1 (en) * | 2018-01-12 | 2019-06-18 | Vinay Advani | LED light projection with multiple lenses |
| CN108864072B (zh) * | 2018-08-01 | 2021-03-23 | 西南大学 | 香豆素噻二酮类化合物及其制备方法和应用 |
| CN116217511B (zh) * | 2023-03-22 | 2024-04-19 | 沈阳药科大学 | 一种双靶点化合物及其制备方法和在制备sEH抑制剂与PPARs激动剂中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3152905A (en) * | 1961-02-09 | 1964-10-13 | Minnesota Mining & Mfg | Sensitizing methine dyes and intermediates, process for preparing same and photographic element containing these dyes |
| JPS63230689A (ja) * | 1987-03-18 | 1988-09-27 | Tanabe Seiyaku Co Ltd | ベンゾオキサジン誘導体 |
| DE69232619T2 (de) | 1991-02-14 | 2002-09-12 | The General Hospital Corp., Charlestown | Intestinale kleeblatt-proteine |
| CN1321153A (zh) | 1999-07-01 | 2001-11-07 | 杰龙公司 | 端粒酶抑制剂及其使用方法 |
| WO2002046226A2 (en) | 2000-12-08 | 2002-06-13 | Novo Nordisk A/S | Trefoil factor 2 (tff2) peptides with moiety attached to asn15 |
| US6452014B1 (en) | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
| WO2002051419A2 (en) | 2000-12-22 | 2002-07-04 | K.U. Leuven Research & Development | A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv |
| EP1401481A1 (en) | 2001-06-14 | 2004-03-31 | Novo Nordisk A/S | Mucosal repair by tff dimer peptides |
| HUP0401492A3 (en) * | 2001-09-14 | 2008-05-28 | Novo Nordisk As | Novel ligands for the hisb10 zn2+ sites of r-state insulin hexa |
| EP1551396A1 (en) * | 2002-09-26 | 2005-07-13 | Pintex Pharmaceuticals, Inc. | Pin1-modulating compounds and methods of use thereof |
| WO2004064860A1 (en) * | 2003-01-17 | 2004-08-05 | Children's Hospital Medical Center | Use of tff2, or agents inducing tff2, in the therapy of allergies |
| CN1205934C (zh) | 2003-01-20 | 2005-06-15 | 鲁南制药股份有限公司 | 治疗高血脂症的组合物 |
| BRPI0516219A (pt) * | 2004-09-28 | 2008-08-26 | Otsuka Pharma Co Ltd | composto de carboestirila |
-
2005
- 2005-09-26 BR BRPI0516219-0A patent/BRPI0516219A/pt not_active IP Right Cessation
- 2005-09-26 MX MX2007003735A patent/MX2007003735A/es active IP Right Grant
- 2005-09-26 KR KR1020077014064A patent/KR100840465B1/ko not_active Expired - Fee Related
- 2005-09-26 EP EP11191504A patent/EP2426128A1/en not_active Withdrawn
- 2005-09-26 JP JP2006519041A patent/JP3906471B1/ja not_active Expired - Fee Related
- 2005-09-26 AU AU2005288080A patent/AU2005288080B2/en not_active Ceased
- 2005-09-26 WO PCT/JP2005/018217 patent/WO2006035954A1/en not_active Ceased
- 2005-09-26 EP EP05788152A patent/EP1797082B1/en not_active Not-in-force
- 2005-09-26 ES ES05788152T patent/ES2393197T3/es active Active
- 2005-09-26 US US10/582,014 patent/US7777038B2/en not_active Expired - Fee Related
- 2005-09-26 KR KR1020077009483A patent/KR100823414B1/ko not_active Expired - Fee Related
- 2005-09-26 RU RU2007116147/04A patent/RU2430920C2/ru not_active IP Right Cessation
- 2005-09-26 CA CA2580811A patent/CA2580811C/en not_active Expired - Fee Related
- 2005-09-26 CN CN2005800370900A patent/CN101068810B/zh not_active Expired - Fee Related
- 2005-09-27 TW TW094133508A patent/TWI353353B/zh not_active IP Right Cessation
- 2005-09-28 AR ARP050104086A patent/AR055193A1/es unknown
-
2007
- 2007-02-28 IL IL181630A patent/IL181630A0/en unknown
- 2007-03-16 ZA ZA200702228A patent/ZA200702228B/xx unknown
-
2009
- 2009-11-03 US US12/611,921 patent/US8362252B2/en not_active Expired - Fee Related
-
2011
- 2011-01-20 IL IL210756A patent/IL210756A0/en unknown
- 2011-05-25 AU AU2011202454A patent/AU2011202454B2/en not_active Ceased
- 2011-06-07 RU RU2011123036/04A patent/RU2011123036A/ru not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0516219A (pt) | composto de carboestirila | |
| BR0311494A (pt) | Novos indóis substituìdos | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| NO20074615L (no) | Dihydrotienopyrimidiner for behandling av inflamatoriske sykdommer | |
| BRPI0410711A (pt) | novos compostos | |
| NO20083710L (no) | Dihydrotienopyrimidin for behandling av betennelsesforstyrrelser | |
| MA31314B1 (fr) | Derives de pleuromutiline pour le traitement de maladies transmises par des microbes | |
| DE60129806D1 (de) | Neue bizyklische verbindungen | |
| MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| MY141229A (en) | Piperidine-benzenesulfonamide derivatives | |
| ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| IS6459A (is) | Arýl sambrædd azapólýsýklísk efnasambönd | |
| ATE450514T1 (de) | Piperazinylalkylpyrazol-derivate zur verwendung als selektive calciumkanalblocker des t-typs und verfahren zu ihrer herstellung | |
| PL1696905T3 (pl) | Zastosowanie podstawionych 2-aminotetralin do zapobiegawczego leczenia choroby parkinsona | |
| BRPI0414266A (pt) | derivados de tiazolopiridina como ligandos receptores da adenosina | |
| BRPI0408591A (pt) | derivados de 6,7,8,9-tetrahidropirimido[1,2-a] pirimidin-4-ona 8-substituìda | |
| CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
| BR0315846A (pt) | Tratamento farmacológico para apnéia do sono | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| BRPI0407055A (pt) | Derivados de isotiazol | |
| ATE526967T1 (de) | Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum | |
| NO20074617L (no) | Nye forbindelser for behandling av inflamotoriske sykdommer | |
| MX2007006357A (es) | Pteridinas sustituidas para el tratamiento de enfermedades inflamatorias. | |
| MY136718A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
| MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 8A, 9A E 10A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |